Macular Disease
15
1
1
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.7%
1 terminated out of 15 trials
85.7%
-0.8% vs benchmark
7%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Implementation of the NEDS EyeCTester App
Novel Glaucoma Diagnostics
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
High Resolution Optical Coherence Tomography
Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery
Standard Cut Rate 27-Gauge System Versus Ultrahigh-Speed 27-Gauge System in Macular Surgery
Translation of Eye Movement Reading Training to Clinical Practice
Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy
Polarization Perception in Health and Disease. Testing a New Sight Test
CEI Van Outreach Screening Study
Cohort Study of the Clinical Course of Macular Diseases in Kagawa
Epiretinal Proliferation in Eyes With Full Thickness Macular Hole
Cohort Study of the Clinical Course of Macular Diseases in Japanese
Clinicopathologic Findings for Macular Disease